Stay updated with breaking news from Membrane Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bicycle Therapeutics (NASDAQ:BCYC – Get Rating) issued its earnings results on Thursday. The company reported ($0.93) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.25), MarketWatch Earnings reports. Bicycle Therapeutics had a negative return on equity of 35.59% and a negative net margin of 568.71%. Shares of NASDAQ BCYC traded down $1.20 […]
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) have received a consensus rating of “Buy” from the thirteen research firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average twelve-month target price among brokerages […]
Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Membrane Bioreactor Market by Membrane Type (Hollow fiber, Flat sheet, Multi-tubular), System...
Brokerages expect Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) to report sales of $3.46 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Bicycle Therapeutics’ earnings, with estimates ranging from $2.00 million to $5.10 million. Bicycle Therapeutics posted sales of $1.81 million during the same quarter last year, […]
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) have earned an average rating of “Buy” from the eleven ratings firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price objective […]